180 Non Current Assets Total vs Non Current Liabilities Total Analysis
| ATNF Stock | USD 2.83 0.07 2.41% |
180 Life financial indicator trend analysis is way more than just evaluating 180 Life Sciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether 180 Life Sciences is a good investment. Please check the relationship between 180 Life Non Current Assets Total and its Non Current Liabilities Total accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in 180 Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Non Current Assets Total vs Non Current Liabilities Total
Non Current Assets Total vs Non Current Liabilities Total Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of 180 Life Sciences Non Current Assets Total account and Non Current Liabilities Total. At this time, the significance of the direction appears to have very strong relationship.
The correlation between 180 Life's Non Current Assets Total and Non Current Liabilities Total is 0.83. Overlapping area represents the amount of variation of Non Current Assets Total that can explain the historical movement of Non Current Liabilities Total in the same time period over historical financial statements of 180 Life Sciences, assuming nothing else is changed. The correlation between historical values of 180 Life's Non Current Assets Total and Non Current Liabilities Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Assets Total of 180 Life Sciences are associated (or correlated) with its Non Current Liabilities Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Total has no effect on the direction of Non Current Assets Total i.e., 180 Life's Non Current Assets Total and Non Current Liabilities Total go up and down completely randomly.
Correlation Coefficient | 0.83 |
| Relationship Direction | Positive |
| Relationship Strength | Strong |
Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.Non Current Liabilities Total
Most indicators from 180 Life's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into 180 Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in 180 Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. The current Selling General Administrative is estimated to decrease to about 6.4 M. The 180 Life's current Tax Provision is estimated to increase to about (3.1 M)
| 2022 | 2023 | 2024 (projected) | Research Development | 2.4M | 2.8M | 2.7M | Depreciation And Amortization | 109.0K | 105.7K | 102.8K |
180 Life fundamental ratios Correlations
Click cells to compare fundamentals
180 Life Account Relationship Matchups
High Positive Relationship
High Negative Relationship
180 Life fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 51.9M | 55.5M | 62.7M | 19.7M | 5.3M | 5.0M | |
| Total Current Liabilities | 9.6M | 21.4M | 19.7M | 5.7M | 5.1M | 8.6M | |
| Total Stockholder Equity | 38.6M | 30.3M | 39.3M | 11.3M | (127.7K) | (121.3K) | |
| Retained Earnings | (37.5M) | (48.4M) | (68.7M) | (107.4M) | (127.3M) | (121.0M) | |
| Cash And Short Term Investments | 118.4M | 83.4K | 8.2M | 7.0M | 2.0M | 1.9M | |
| Total Liab | 13.3M | 25.2M | 23.4M | 8.3M | 5.4M | 5.1M | |
| Total Current Assets | 748.3K | 4.0M | 11.2M | 8.9M | 3.6M | 4.0M | |
| Common Stock | 1.4K | 2.6K | 3.4K | 375.0 | 54.0 | 51.3 | |
| Other Current Liab | 2.0M | 4.4M | 17.2M | 2.5M | 1.9M | 1.8M | |
| Net Debt | 3.4M | 1.7M | (6.3M) | (5.6M) | (921.7K) | (967.8K) | |
| Cash | 83.4K | 2.1M | 8.2M | 7.0M | 2.0M | 3.2M | |
| Non Current Assets Total | 51.1M | 51.5M | 51.5M | 10.7M | 1.6M | 1.5M | |
| Common Stock Shares Outstanding | 29.0K | 18.2M | 82.5K | 100.0K | 379.1K | 360.1K | |
| Liabilities And Stockholders Equity | 51.9M | 25.2M | 62.7M | 19.7M | 5.3M | 5.0M | |
| Non Current Liabilities Total | 3.7M | 3.8M | 3.7M | 2.6M | 324.6K | 308.4K | |
| Other Stockholder Equity | 75.9M | 636.9K | 107.2M | 121.6M | 130.1M | 136.6M | |
| Accounts Payable | 4.1M | 8.5M | 586.6K | 1.8M | 2.2M | 2.3M | |
| Net Receivables | 328.3K | 784.6K | 694.6K | 621.0K | 279.0K | 535.8K | |
| Other Current Assets | 35.0K | 14.4K | 3.0M | 1.3M | 1.7M | 1.1M |
Currently Active Assets on Macroaxis
When determining whether 180 Life Sciences is a strong investment it is important to analyze 180 Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact 180 Life's future performance. For an informed investment choice regarding 180 Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in 180 Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 180 Life. If investors know 180 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 180 Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 7.98 | Return On Assets (0.64) | Return On Equity (3.99) |
The market value of 180 Life Sciences is measured differently than its book value, which is the value of 180 that is recorded on the company's balance sheet. Investors also form their own opinion of 180 Life's value that differs from its market value or its book value, called intrinsic value, which is 180 Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 180 Life's market value can be influenced by many factors that don't directly affect 180 Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 180 Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if 180 Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 180 Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.